Lonza Group AG SIX:LONN:
LONZA EXPANDS STRATEGIC COLLABORATION WITH LEADING US BIOPHARMACEUTICAL COMPANY
ANNOUNCES EXPANDED STRATEGIC COLLABORATION WITH LEADING US BIOPHARMACEUTICAL COMPANY
COLLABORATION HAS POTENTIAL TO DELIVER MULTI-BILLION CHF CUMULATIVE VALUE
EXPANSION ADDS TWO COMMERCIAL BIOLOGICS PROGRAMS WITH OPTION FOR TWO MORE